FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance. Li F, Niu M, Qin K, Guo R, et al. Oncogene 2022 Dec 2. doi: 10.1038/s41388-022-02559.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li F, Niu M, Qin K, Guo R, et al. FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance. Oncogene 2022 Dec 2. doi: 10.1038/s41388-022-02559.
PMID: 36460773